Polymorphisms in apoptosis-related genes and survival of patients with early-stage non-small-cell lung cancer

Annals of Surgical Oncology

Volumn 17, Issue 10, 2010, Pages 2608-2618

  Lee, Eung Bae ^a   Jeon, Hyo Sung ^a   Yoo, Seung Soo ^a   Choi, Yi Young ^a   Kang, Hyo Gyoung ^a   Cho, Sukki ^a   Cha, Sung Ick ^a   Choi, Jin Eun ^a   Park, Tae In ^a   Lee, Byung Heon ^a   Park, Rang Woon ^a   Kim, In San ^a   Kang, Young Mo ^a   Kim, Chang Ho ^a   Jheon, Sanghoon ^b   Jung, Tae Hoon ^a   Park, Jae Yong ^a  

^a Kyungpook National University Hospital   (South Korea)

^b Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; APOPTOSIS; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CONFIDENCE INTERVAL; DISEASE FREE SURVIVAL; FEMALE; GENE FREQUENCY; GENOTYPE; HAZARD RATIO; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADENOCARCINOMA; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DNA, NEOPLASM; FEMALE; GENOTYPE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RECEPTORS, TNF-RELATED APOPTOSIS-INDUCING LIGAND; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; REPRESSOR PROTEINS; SURVIVAL RATE;

EID: 78049479785     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-1082-4     Document Type: Article

References (37)

1. DM Parkin F Bray J Ferlay P Pisani 2005 Global cancer statistics, 2002 CA Cancer J Clin. 55 74 108 10.3322/canjclin.55.2.74 15761078
2. R Arriagada B Bergman A Dunant T Le Chevalier JP Pignon J Vansteenkiste 2004 Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med. 350 351 360 10.1056/NEJMoa031644 14736927
3. LE Coate T John MS Tsao FA Shepherd 2009 Molecular predictive and prognostic markers in non-small cell lung cancer Lancet Oncol. 10 1001 1010 1:CAS:528:DC%2BD1MXhtFOqurjE 10.1016/S1470-2045(09)70155-X 19796752
4. M Raff 1998 Cell suicide for beginners Nature. 396 119 122 1:CAS:528:DyaK1cXnslantLw%3D 10.1038/24055 9823889
5. SW Lowe AW Lin 2000 Apoptosis in cancer Carcinogenesis. 21 485 495 1:CAS:528:DC%2BD3cXitVeitro%3D 10.1093/carcin/21.3.485 10688869
6. GI Evan KH Vousden 2001 Proliferation, cell cycle and apoptosis in cancer Nature. 411 342 348 1:CAS:528:DC%2BD3MXktVSjsr8%3D 10.1038/35077213 11357141
7. N Shivapurkar J Reddy PM Chaudhary AF Gazdar 2003 Apoptosis and lung cancer: a review J Cell Biochem. 88 885 898 1:CAS:528:DC%2BD3sXisVKktLg%3D 10.1002/jcb.10440 12616528
8. A Schmitz J Bayer N Dechamps G Thomas 2003 Intrinsci susceptibility to radiation-induced apoptosis of human lymphocyte subpopulations Int J Radat Oncol Biol Phys. 57 769 778 10.1016/S0360-3016(03)00637-0
9. RS Camplejohn S Hodgson N Carter BS Kato TD Spector 2006 Heretability of DNA-damage-induced apoptosis and its relationship with age in lymphocytes from female twins Br J Cancer. 95 520 524 1:CAS:528:DC%2BD28XotV2rur8%3D 10.1038/sj.bjc.6603257 16819540
10. B Chen S Liu XL Wang W Xu Y Li WH Zhao, et al. 2009 TRAIL-R1 polymorphisms and cancer susceptibility: an evidence-based meta-analysis Eur J Cancer. 45 2598 2605 1:CAS:528:DC%2BD1MXhtVKls7jN 10.1016/j.ejca.2009.06.023 19643596
11. JS Jang KM Kim KH Kang, et al. 2008 Polymorphisms in the survivin gene and the risk of lung cancer Lung Cancer. 60 31 39 10.1016/j.lungcan.2007.09.008 17961802
12. Y Li LX Qiu XK Shen XJ Lv XP Qian Y Song 2009 A meta-analysis of TP53 codon 72 polymorphism and lung cancer risk: evidence from 15, 857 subjects Lung Cancer. 66 15 21 10.1016/j.lungcan.2008.12.009 19178978
13. R Gupta SC Sharma SN Das 2008 Association of TNF-alpha and TNFR1 promoters and 3' UTR region of TNFR2 gene polymorphisms with genetic susceptibility to tobacco-related oral carcinoma in Asian Indians Oral Oncol. 44 455 463 1:CAS:528:DC%2BD1cXls12qtbk%3D 10.1016/j.oraloncology.2007.06.003 18206417
14. HY Yuan JJ Chiou WH Tseng, et al. 2006 FASTSNP: an always up-to-date and extended service for SNP function analysis and prioritization Nucleic Acids Res. 34 W635 W641 1:CAS:528:DC%2BD28Xps1yhs7c%3D 10.1093/nar/gkl236 16845089
15. M Stephens P Donnelly 2003 A comparison of Bayesian methods for haplotype reconstruction from population genotype data Am J Hum Genet. 73 1162 1169 1:CAS:528:DC%2BD3sXptVGnsL4%3D 10.1086/379378 14574645
16. SB Gabriel SF Schaffner H Nguyen, et al. 2002 The structure of haplotype blocks in the human genome Science. 296 2225 2229 1:CAS:528:DC%2BD38XkvFGhtrc%3D 10.1126/science.1069424 12029063
17. RM Locksley N Killeen MJ Lenardo 2001 The TNF and TNF receptor superfamilies: integrating mammalian biology Cell. 104 487 501 1:CAS:528:DC%2BD3MXis1KksrY%3D 10.1016/S0092-8674(01)00237-9 11239407
18. BB Aggarwal 2003 Signaling pathways of the TNF superfamily: a double-edged sword Nat Rev Immunol. 3 745 756 1:CAS:528:DC%2BD3sXmvVWmtb0%3D 10.1038/nri1184 12949498
19. JY Han EK Hong BG Choi, et al. 2003 Death receptor 5 and Bcl-2 protein expression as predictors of tumor response to gemcitabine and cisplatin in patients with advanced non-small cell lung cancer Med Oncol 20 355 362 1:CAS:528:DC%2BD2cXjtFyltw%3D%3D 10.1385/MO:20:4:355 14716031
20. H Jin R Yang S Fong, et al. 2004 Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand cooperates with chemotherapy to inhibit orthotopic lung growth and improve survival Cancer Res 64 4900 4905 1:CAS:528:DC%2BD2cXls1Omtro%3D 10.1158/0008-5472.CAN-04-0408 15256461
21. K Leithner E Stacher R Wurm, et al. 2009 Nuclear and cytoplasmic death receptor 5 as prognostic factors in patients with non-small cell lung cancer treated with chemotherapy Lung Cancer 65 98 104 10.1016/j.lungcan.2008.10.015 19081160
22. L Zhuang CS Lee RA Scolyer 2006 Progression of melanoma is associated with decreased expression of death receptors for tumor necrosis factor-related apoptosis-inducing ligand Hum Pathol. 37 1286 1294 1:CAS:528: DC%2BD28XpvV2lsrY%3D 10.1016/j.humpath.2006.04.026 16949935
23. DR Camidge 2007 The potential of death receptor 4- and 5-directed therapies in the treatment of lung cancer Clin Lung Cancer. 8 413 419 1:CAS:528:DC%2BD2sXhtVShtrrP 10.3816/CLC.2007.n.024 17681093
24. H Jin R Yang J Ross, et al. 2008 Cooperation of the agonistic DR5 antibody apomab with chemotherapy to inhibit orthotopic lung tumor growth and improve survival Clin Cancer Res 14 7733 7740 1:CAS:528:DC%2BD1cXhsVegtrbE 10.1158/1078-0432.CCR-08-0670 19047100
25. A Ashkenazi P Holland SG Eckhardt 2008 Ligand-based targeting of apoptosis in cancer: the potential of recombinant human apoptosis ligand 2/tumor necrosis factor-related apoptosis-inducing ligand (rhApo2L/TRAIL) J Clin Oncol. 26 3621 3630 1:CAS:528:DC%2BD1cXpvVWmtbw%3D 10.1200/JCO.2007.15.7198 18640940
26. SG Hymowitz HW Christinger G Fuh, et al. 1999 Triggering cell death: the crystal structure of Apo2L/TRAIL in a complex with death receptor 5 Mol Cell. 4 563 571 1:CAS:528:DyaK1MXntFCgsLg%3D 10.1016/S1097-2765(00)80207-5 10549288
27. F Balkwill 2002 Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13 135 141 1:CAS:528:DC%2BD38XitFWhsrY%3D 10.1016/S1359-6101(01)00020-X 11900989
28. S Mocellin CR Rossi P Pilati D Nitti 2005 Tumor necrosis factor, cancer and anticancer therapy Cytokine Growth Factor Rev. 16 35 53 1:CAS:528: DC%2BD2MXhslChsr0%3D 10.1016/j.cytogfr.2004.11.001 15733831
29. Kim S, Moon SM, Kim YS, et al. TNFR1 promoter -329G/T polymorphism results in allele specific repression in TNFR1 expression. Biochem Biophys Res Commun. 2008;368-401.
30. JP Yang M Hori T Sande T Okamoto 1999 Identification of a novel inhibitor of nuclear factor-kB, RelA-associated inhibitor J Biol Chem. 18 6938 6947
31. D Bergamaschi Y Samuels NJ O'Neil, et al. 2003 iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human Nat Genet 33 162 167 1:CAS:528:DC%2BD3sXnsFSltA%3D%3D 10.1038/ng1070 12524540
32. N Grabe 2002 Alibaba2: context specific identification of transcription factor binding sites In Silico Biol. 2 S1 1 11808873
33. U Vogel I Laros NR Jacobsen, et al. 2004 Two regions in chromosome 19q13.2-3 are associated with risk of lung cancer Mut Res 546 65 74 1:CAS:528:DC%2BD2cXnvVeisg%3D%3D
34. AS Neumann EM Sturgis Q Wei 2005 Nucleotide excision repair as a marker for susceptibility to tobacco-related cancers: a review of molecular epidemiological studies Mol Carcinog. 42 65 92 1:CAS:528:DC%2BD2MXhtVWks7o%3D 10.1002/mc.20069 15682379
35. Takenaka T, Yano T, Kiyohara C, et al. Effects of excision repair cross-complementation group 1 (ERCC1) single nucleotide polymorphisms on the prognosis of non-small cell lung cancer patients. Lung Cancer. 2009 (in press).
36. SJ Chanock T Manolio M Boehnke, et al. 2007 Replicating genotype-phenotype associations Nature. 447 655 660 1:CAS:528: DC%2BD2sXmtFemur4%3D 10.1038/447655a 17554299
37. JMG Taylor DP Ankerst RR Andridge 2008 Validation of biomark-based prediction models Clin Cancer Res. 14 5977 5983 10.1158/1078-0432.CCR-07-4534 18829476